<b>Conclusions</b>: In patients with ASCVD, compared with use of statins, use of PCSK9 inhibitors is associated with reduced risks of AMD and dry AMD, suggesting a potential novel strategy for managing a condition with limited therapeutic options. The gene discussed is PCSK9; the disease is age-related macular degeneration.